Login

GHP Specialty Care Presentation - Daniel Ohman, CEO, GHP Specialty Care AB (publ) 00:00:00

Share On Facebook Share On Twitter

GHP Specialty Care - Presentation

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Focused on investing in brilliant engineers|Dave Fontenot,General Partner,Backend Capital / Hf0
00:10:00
Air New Zealand CEO Greg Foran on Weighing Passengers and Upcoming Sleep Pods | Greg Foran, CEO, Air New Zealand Ltd .
00:10:00
Enhancing Advisor Efficiency: Insights from The Rudin Group, Celent, and NexJ Systems - April Rudin | Founder and President, The Rudin Group
00:10:00
Action SA reveals 18-member 'cabinet in waiting' | André Coetzee, CEO, Action SAACT:WSE
00:10:00
Crosscut is the largest early-stage venture capital firm with deep operational and investing expertise|Brian Garrett,Managing Director,Crosscut Ventures
00:10:00
AXA IM Research Award 2022: Supporting Professor Ana Queiros' Research in Blue Carbon
00:00:00
US companies set the benchmark for Motif Bio - Graham Lumsden, chief executive of Motif Bio PLC
00:10:00
MOD Resources' Expansion and London Listing Plans Highlighted at One-to-One Mining Conference in London
00:10:00
Neil Woodyer CEO of Aris Mining in an interview | Neil Woodyer, CEO and Director, Aris Mining Corporation (IE)
00:10:00
Rugby Resources’ Gayle Simpson Highlights Exploration Projects and Track Record at Industry Forum
00:10:00
Steve Klar on Asset Management's Role in Achieving Sustainable Development Goals: Balancing Returns and Positive Impact - A Discussion at the UN World Investment Forum by Force for Good
00:10:00
Investing Essentials: Insights from Allodium Investment Consultants | David J. Bromelkamp - CEO of Allodium Investment Consultants

© 2017 - Neuhu+